-
The lancet oncology · Nov 2020
Comment LetterDabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer - Authors' reply.
- Vivek Subbiah, Ulrik Lassen, Eduard Gasal, Paul Burgess, and Zev A Wainberg.
- Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: vsubbiah@mdanderson.org.
- Lancet Oncol. 2020 Nov 1; 21 (11): e516.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..